U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898905) titled 'Hyperfractionated Dual Equivalent Fractionated Radiation Therapy' on March 18.
Brief Summary: This study evaluates the feasibility and safety of a novel method for comparing the effectiveness of hypofractionated versus hyperfractionated radiation therapy in participants with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) undergoing T-cell redirection therapies (CAR T-cell therapy or bispecific antibodies).
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Diffuse Large B-Cell Lymphoma
Intervention:
OTHER: Bridging Radiation Therapy
Study seeks to compare the hypofractionated radiation therapy...